These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33205499)

  • 1. 3D Oxygen-Enhanced MRI at 3T MR System: Comparison With Thin-Section CT of Quantitative Capability for Pulmonary Functional Loss Assessment and Clinical Stage Classification of COPD in Smokers.
    Ohno Y; Yui M; Yoshikawa T; Seki S; Takenaka D; Kassai Y; Hattori H; Murayama K; Toyama H
    J Magn Reson Imaging; 2021 Apr; 53(4):1042-1051. PubMed ID: 33205499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease.
    Ohno Y; Iwasawa T; Seo JB; Koyama H; Takahashi H; Oh YM; Nishimura Y; Sugimura K
    Am J Respir Crit Care Med; 2008 May; 177(10):1095-102. PubMed ID: 18276941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Takahashi M; Van Cauteren M; Sugimura K
    AJR Am J Roentgenol; 2011 Aug; 197(2):W279-85. PubMed ID: 21785054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of capability of dynamic O₂-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Nishimura Y; Sugimura K
    Eur J Radiol; 2012 May; 81(5):1068-75. PubMed ID: 21392914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D lung motion assessments on inspiratory/expiratory thin-section CT: Capability for pulmonary functional loss of smoking-related COPD in comparison with lung destruction and air trapping.
    Koyama H; Ohno Y; Fujisawa Y; Seki S; Negi N; Murakami T; Yoshikawa T; Sugihara N; Nishimura Y; Sugimura K
    Eur J Radiol; 2016 Feb; 85(2):352-9. PubMed ID: 26781140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD.
    Ohno Y; Koyama H; Nogami M; Takenaka D; Matsumoto S; Obara M; Sugimura K
    AJR Am J Roentgenol; 2008 Feb; 190(2):W93-9. PubMed ID: 18212207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial for: "3D Oxygen-Enhanced MR Imaging at 3T MR System: Comparison With Thin-Section CT of Quantitative Capability for Pulmonary Functional Loss Assessment and Clinical Stage Classification of COPD in Smokers".
    Cowell GW
    J Magn Reson Imaging; 2021 Apr; 53(4):1052-1053. PubMed ID: 33354851
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography.
    Xia Y; Guan Y; Fan L; Liu SY; Yu H; Zhao LM; Li B
    COPD; 2014 Sep; 11(5):510-20. PubMed ID: 25211632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary 3 T MRI with ultrashort TEs: influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers.
    Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Seki S; Obara M; van Cauteren M; Takahashi M; Sugimura K
    J Magn Reson Imaging; 2014 Apr; 39(4):988-97. PubMed ID: 24123342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional lung MRI in chronic obstructive pulmonary disease: comparison of T1 mapping, oxygen-enhanced T1 mapping and dynamic contrast enhanced perfusion.
    Jobst BJ; Triphan SM; Sedlaczek O; Anjorin A; Kauczor HU; Biederer J; Ley-Zaporozhan J; Ley S; Wielpütz MO
    PLoS One; 2015; 10(3):e0121520. PubMed ID: 25822195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative analysis of emphysema and air trapping at inspiratory and expiratory phase multi-slice spiral CT scan in smokers: correlation with pulmonary function test].
    Zhang D; Guan Y; Fan L; Xia Y; Liu SY
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1467-1473. PubMed ID: 29804412
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of quantitative regional perfusion-weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium-enhanced regional pulmonary perfusion MRI in COPD patients.
    Kaireit TF; Voskrebenzev A; Gutberlet M; Freise J; Jobst B; Kauczor HU; Welte T; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2019 Apr; 49(4):1122-1132. PubMed ID: 30350440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractal analysis of low attenuation clusters on computed tomography in chronic obstructive pulmonary disease.
    Tanabe N; Muro S; Sato S; Oguma T; Sato A; Hirai T
    BMC Pulm Med; 2018 Aug; 18(1):144. PubMed ID: 30157833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography.
    Tsushima K; Sone S; Fujimoto K; Kubo K; Morita S; Takegami M; Fukuhara S
    COPD; 2010 Apr; 7(2):117-25. PubMed ID: 20397812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
    Capaldi DP; Zha N; Guo F; Pike D; McCormack DG; Kirby M; Parraga G
    Radiology; 2016 May; 279(2):597-608. PubMed ID: 26744928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of quantitative regional ventilation-weighted fourier decomposition MRI with dynamic fluorinated gas washout MRI and lung function testing in COPD patients.
    Kaireit TF; Gutberlet M; Voskrebenzev A; Freise J; Welte T; Hohlfeld JM; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2018 Jun; 47(6):1534-1541. PubMed ID: 29160020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of cross-sectional area of small pulmonary vessels in patients with COPD using inspiratory and expiratory MDCT.
    Matsuura Y; Kawata N; Yanagawa N; Sugiura T; Sakurai Y; Sato M; Iesato K; Terada J; Sakao S; Tada Y; Tanabe N; Suzuki Y; Tatsumi K
    Eur J Radiol; 2013 Oct; 82(10):1804-10. PubMed ID: 23769190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Pulmonary Ventilation Using 3D Ventilation Flow Capacity-Weighted and Ventilation-Weighted Maps From 3D Ultrashort Echo Time (UTE) MRI.
    Lee S; Lee HY; Park J; Kim H; Park JY
    J Magn Reson Imaging; 2024 Aug; 60(2):483-494. PubMed ID: 37970646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echo Time-Dependent Observed Lung T
    Triphan SMF; Weinheimer O; Gutberlet M; Heußel CP; Vogel-Claussen J; Herth F; Vogelmeier CF; Jörres RA; Kauczor HU; Wielpütz MO; Biederer J; Jobst BJ;
    J Magn Reson Imaging; 2021 Nov; 54(5):1562-1571. PubMed ID: 34050576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging.
    Fan L; Xia Y; Guan Y; Yu H; Zhang TF; Liu SY; Li B
    Eur Radiol; 2013 May; 23(5):1234-41. PubMed ID: 23263604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.